Pathogen List Development Guided By Limited Therapy Availability – Cmte.

Limited treatment availability due to multi-drug resistance should be the most important factor in determining whether a pathogen is "of public health importance" for drug development, members of FDA's Anti-Infective Drugs Advisory Committee said